Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/04/2003US20030165588 Cyclooxygenase inhibitors; antiinflammatory drugs
09/04/2003US20030165586 Synergistic mixture; anticancer agents; side effect reduction
09/04/2003US20030165585 Xanthine-containing compositions for oral administration and uses related thereto
09/04/2003US20030165583 Compositions and methods for enhancing therapeutic effects
09/04/2003US20030165582 Plant extracts; aging resistance; skin disorders
09/04/2003US20030165580 Safe pharmaceutical composition for treatment and prevention of gynecological disease
09/04/2003US20030165576 Antitumor effect potentiators
09/04/2003US20030165575 Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders
09/04/2003US20030165572 Powder mixture containing starch; drying; anticholesterol agents
09/04/2003US20030165571 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
09/04/2003US20030165570 Pharmaceutical compositions containing micronized bicyclic drugs
09/04/2003US20030165568 Stabilized steroidal suspension
09/04/2003US20030165566 Sedative non-benzodiazepine formulations
09/04/2003US20030165565 Diltiazem; controlled release; presleep administering; cardiovascular disorders
09/04/2003US20030165564 High speed releasing; storage stability
09/04/2003US20030165563 Dry blend tablet
09/04/2003US20030165561 Substituted diphenyl heterocycles useful for treating HCV infection
09/04/2003US20030165559 Grampositive bactericide using cerulenin, triclosan, chloroprene
09/04/2003US20030165558 Antiallergic agent
09/04/2003US20030165552 Compositions and methods for delivery of skin cosmeceuticals
09/04/2003US20030165545 Contact lenses; mixture of oil, water and surfactants
09/04/2003US20030165544 Injectable aqueous dispersions of propofol
09/04/2003US20030165537 Vaccination against host cell-associated herpes viruses
09/04/2003US20030165533 Antiinflammatory agents; antiproliferative agents; topical applying
09/04/2003US20030165520 Attenuated forms of bovine viral diarrhea virus
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165486 Compositions and methods for the induction of retinal detachments
09/04/2003US20030165464 In vivo stimulation of angiogenic activity
09/04/2003US20030165459 Binding to tumor necrosis factor
09/04/2003US20030165457 Analgesics; antiinflammatory agents; antiischemic agents; antiscarring agents; wound healing agents
09/04/2003US20030165456 Mixture containing plant extracts
09/04/2003US20030165449 Lipase inhibiting composition
09/04/2003US20030165444 Lipochroman-6 as no-synthase inhibitor and uses
09/04/2003US20030165438 Water-free ubichinon concentrate
09/04/2003US20030165437 Aerosos formulations containing P134a and particulate medicament
09/04/2003US20030165436 Formulations for use in inhaler devices
09/04/2003US20030165435 Using ethanol solvent
09/04/2003US20030165434 Delivery of polynucleotide agents to the central nervous system
09/04/2003US20030165426 Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy
09/04/2003US20030163931 Method for making homogeneous spray-dried soild amorphous drug dispersions utilizing modified spray-drying apparatus
09/04/2003CA2855045A1 Topical dapsone for the treatment of acne
09/04/2003CA2833470A1 Processes for preparing form 1 zd1839 polymorph
09/04/2003CA2776702A1 Topical dapsone for the treatment of acne
09/04/2003CA2702297A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003CA2696267A1 Methods for preventing or treating cardiac arrhythmia
09/04/2003CA2662899A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
09/04/2003CA2505984A1 Treatment of effect of chemicals with their ultradilute stereoisomers
09/04/2003CA2503094A1 Therapeutic methods for acute myeloid leukemia
09/04/2003CA2479812A1 Glutaminyl based dpiv inhibitors
09/04/2003CA2477741A1 Nucleotide mimics and their prodrugs
09/04/2003CA2477726A1 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003CA2477634A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003CA2477555A1 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
09/04/2003CA2477417A1 Methods and products based on oligomerization of stress proteins
09/04/2003CA2477379A1 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/04/2003CA2477350A1 Novel crystalline forms of the anti-cancer compound zd1839
09/04/2003CA2477347A1 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
09/04/2003CA2477344A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
09/04/2003CA2477328A1 Pyridyl tricyclic compounds as farnesyl protein transferase inhibitors and antitumor agents
09/04/2003CA2477287A1 Uracil-thioether
09/04/2003CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes
09/04/2003CA2477281A1 Method of using modified oligonucleotides for hepatic delivery
09/04/2003CA2477245A1 Bipolar trans carotenoid salts and their uses
09/04/2003CA2477224A1 Piperidine ouracil used as a medicament for treating bacterial infections
09/04/2003CA2477222A1 Intraspinal continuous infusion of midazolam hydrochloride for the treatment of pain
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003CA2477178A1 Administration of agents for the treatment of inflammation
09/04/2003CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003CA2477105A1 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
09/04/2003CA2477049A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
09/04/2003CA2477031A1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2477005A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
09/04/2003CA2476994A1 Methods of extending corneal graft survival
09/04/2003CA2476972A1 Pharmaceutical dosage form and method for the production thereof
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476782A1 Carboxyfullerenes and methods of use thereof
09/04/2003CA2476723A1 Preparation of paroxetine involving novel intermediates
09/04/2003CA2476664A1 Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2476480A1 Methods of making hypermutable cells using pmsr homologs
09/04/2003CA2476316A1 Beta3-adrenergic receptor agonists
09/04/2003CA2476173A1 Arylsulfone derivatives
09/04/2003CA2476041A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/04/2003CA2476038A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/04/2003CA2475774A1 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
09/04/2003CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/04/2003CA2475655A1 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003CA2475598A1 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
09/04/2003CA2475433A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications
09/04/2003CA2475299A1 Thiazole derivatives as npy receptor antagonists
09/04/2003CA2474805A1 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents
09/04/2003CA2474793A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/04/2003CA2473625A1 Oral trimethobenzamide formulations and methods
09/04/2003CA2473602A1 Oral pediatric trimethobenzamide formulations and methods
1 ... 5354 5355 5356 5357 5358 5359 5360 5361 5362 5363 5364 5365 5366 5367 5368 5369 5370 5371 5372 5373 5374 ... 7860